Dexcom makes glucose monitoring systems for patients with diabetes. I don't see Americans getting healthier any time soon, so demand for the company's products should remain high for the foreseeable future.
The stock is just breaking out of a high tight flag pattern. Technically, a high tight flag requires a move up of 100% or more, so DXCM comes up a little short on the initial surge. But the pullback inside the flag was very shallow - well below the 25% allowed in this setup. So for me, it balances out.
On the fundamental side, sales growth is accelerating. +23%, +25%, and +32% for the last three quarters. Earnings are also expected to jump by 40% in 2022.
The stop loss on this trade would be the just beneath the low of the flag at $487.00.
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.